1. Home
  2. OC vs CORT Comparison

OC vs CORT Comparison

Compare OC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owens Corning Inc New

OC

Owens Corning Inc New

HOLD

Current Price

$114.33

Market Cap

9.5B

Sector

Industrials

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$90.17

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OC
CORT
Founded
1938
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
9.7B
IPO Year
2006
2001

Fundamental Metrics

Financial Performance
Metric
OC
CORT
Price
$114.33
$90.17
Analyst Decision
Buy
Buy
Analyst Count
18
5
Target Price
★ $148.50
$141.00
AVG Volume (30 Days)
★ 951.5K
649.2K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 2.71%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.50
0.09
Revenue
N/A
★ $761,407,000.00
Revenue This Year
N/A
$50.53
Revenue Next Year
$2.72
$48.90
P/E Ratio
★ $77.92
$1,194.51
Revenue Growth
N/A
★ 12.79
52 Week Low
$97.53
$28.66
52 Week High
$159.91
$126.38

Technical Indicators

Market Signals
Indicator
OC
CORT
Relative Strength Index (RSI) 43.13 26.74
Support Level $106.24 $87.44
Resistance Level $129.58 $95.11
Average True Range (ATR) 3.87 6.07
MACD 0.86 -2.26
Stochastic Oscillator 49.10 15.94

Price Performance

Historical Comparison
OC
CORT

About OC Owens Corning Inc New

Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: